SCHEMBL22051112

SCHEMBL22051112

CC(Cc1cccc2ccccc12)(c1ccc2cc(N)ccc2c1)c1ccc2cc(N)ccc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 3/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ HSD17B10 Q99714 2/20 0.44
▸ ALOX15 P16050 1/20 0.43
▸ CASP1 P29466 1/20 0.43
▸ CASP7 P55210 1/20 0.43
▸ HBB P68871 1/20 0.43
▸ HIF1A Q16665 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ CYP2D6 P10635 3/20 0.41
▸ SLC6A2 P23975 2/20 0.41
▸ SLC6A4 P31645 2/20 0.41
▸ KCNH2 Q12809 2/20 0.41
▸ NR1I2 O75469 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ ADRA2A P08913 1/20 0.41
▸ ACHE P22303 1/20 0.41
▸ HTR2A P28223 1/20 0.41
▸ SIGMAR1 Q99720 1/20 0.41
▸ MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22051848 0.86 CYP2D6 (0.46) CYP3A4ALDH1A1HSD17B10TDP1CYP2D6
SCHEMBL22051843 0.83 CYP2D6 (0.41) CYP3A4ALDH1A1HSD17B10ALOX15CASP1
SCHEMBL23861369 0.76 MEN1 (0.46) CYP3A4ALDH1A1TDP1CYP2D6SLC6A2
SCHEMBL23861595 0.75 CYP2D6 (0.39) CYP3A4TDP1CYP2D6SLC6A2SLC6A4
SCHEMBL23861597 0.74 HSD17B1 (0.45) ALDH1A1TDP1CYP2D6SLC6A2SLC6A4
SCHEMBL7037475 0.71 CYP1A2 (0.50) ALDH1A1HSD17B10TDP1CYP2D6SLC6A2
SCHEMBL31675157 0.70 CYP2D6 (0.53) ALDH1A1TDP1CYP2D6SLC6A2SLC6A4
SCHEMBL11586023 0.70 CYP2D6 (0.53) ALDH1A1TDP1CYP2D6SLC6A2SLC6A4
SCHEMBL5240009 0.70 CYP2C19 (0.42) CYP3A4ALDH1A1HSD17B10TDP1CYP2D6
Ammonia Solution, Strong SCHEMBL2412475 0.70 CYP1A2 (0.48) TDP1CYP2D6SLC6A2SLC6A4KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200172470-A1 NOVEL (POLY)AMINE COMPOUND, RESIN AND CURED PRODUCT MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2020-06-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200172470-A1 NOVEL (POLY)AMINE COMPOUND, RESIN AND CURED PRODUCT PAM, CBR1, KDM1A CYP3A4 1300/4885ALDH1A1 276/4885HSD17B10 1943/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback